Schedule 13G ownership disclosure

FORTRESS BIOTECH INC

Security class unavailable · CUSIP: 34960Q109

Event date: 2023-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
372,562
Percent of class
4.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-023873
Form type
SC 13G/A
Filer
Fortress Biotech, Inc.
CIK
CIK 1429260
Filed
Feb 14, 2024
Reporting period
Dec 31, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub